Patent · US Expired

Substituted triazine kinase inhibitors

US7205298B2 · kind B2 · utility

2Cited by

0References

10Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Gee-Hong Kuo · Scotch Plains, US
Alan R. DeAngelis · Pennington, US
Aihua Wang · Jamison, US
Yan Zhang · Fort Washington, US
Stuart Emanuel · Doylestown, US
Steve Middleton · Flemington, US

Key dates

Filing date	Jul 18, 2003
Grant date	Apr 17, 2007
Priority date	—
Expiry date	Jan 13, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides substituted 1,3,5-triazine compounds as kinase inhibitors and a method for treating or ameliorating a kinase mediated disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.